Search studies

5 studies found

204869 Phase 2a/b in Ulcerative Colitis

204869 Phase 2a/b in Ulcerative Colitis

1

AMCUC study

AMCUC study

2

LUCENT-1 (NCT 03518086)

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

3

OncoTrack study

OncoTrack attempts to address the core problems of drug-based cancer therapies: the low response rate of patients to their therapies, as well as its inevitable consequence, the low approval rates of oncology drugs. Only about 10% of cancer drug candidates entering clinical development are granted marketing authorization. Our program is based on two seminal developments: significant progress in our ability to analyze the molecular characteristics of individual tumors and patients (predominantl...

4

Pfizer

204869 Phase 2a/b in Ulcerative Colitis

5